Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Ferro

Showing results (371-380 of 420) with videos related to

Pageof 42
Sort By:
European Urology Focus|January 1, 2023
Corrigendum re "A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)" [Eur Urol Focus 2022;8:173-81]Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
Urologic Oncology|March 17, 2020
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorMatteo Ferro, Martha Orsolya Katalin, Carlo Buonerba, et al.
European Urology Oncology|June 4, 2019
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder CancerFrancesco Cantiello, Giorgio I Russo, Mihai Dorin Vartolomei, et al.
Urologic Oncology|June 8, 2022
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancerMatteo Ferro, Biagio Barone, Felice Crocetto, et al.
Nature|April 24, 2024
A magnetar giant flare in the nearby starburst galaxy M82Sandro Mereghetti, Michela Rigoselli, Ruben Salvaterra, et al.
BJU International|December 12, 2024
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomesDhruv Puri, Margaret F Meagher, Zhenjie Wu, et al.
Clinical Genitourinary Cancer|June 10, 2023
Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative GroupAntoin Douglawi, Alireza Ghoreifi, Umberto Carbonara, et al.
World Journal of Urology|July 12, 2018
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancerMatteo Ferro, Mihai Dorin Vartolomei, Giorgio Ivan Russo, et al.
Cancers|July 12, 2025
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative GroupMaxwell Otiato, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, et al.
European Urology Focus|February 7, 2021
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
Pageof 42

Showing results (371-380 of 420) with videos related to

Sort By:
Pageof 42
European Urology Focus|January 1, 2023
Corrigendum re "A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)" [Eur Urol Focus 2022;8:173-81]Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
Urologic Oncology|March 17, 2020
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorMatteo Ferro, Martha Orsolya Katalin, Carlo Buonerba, et al.
European Urology Oncology|June 4, 2019
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder CancerFrancesco Cantiello, Giorgio I Russo, Mihai Dorin Vartolomei, et al.
Urologic Oncology|June 8, 2022
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancerMatteo Ferro, Biagio Barone, Felice Crocetto, et al.
Nature|April 24, 2024
A magnetar giant flare in the nearby starburst galaxy M82Sandro Mereghetti, Michela Rigoselli, Ruben Salvaterra, et al.
BJU International|December 12, 2024
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomesDhruv Puri, Margaret F Meagher, Zhenjie Wu, et al.
Clinical Genitourinary Cancer|June 10, 2023
Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative GroupAntoin Douglawi, Alireza Ghoreifi, Umberto Carbonara, et al.
World Journal of Urology|July 12, 2018
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancerMatteo Ferro, Mihai Dorin Vartolomei, Giorgio Ivan Russo, et al.
Cancers|July 12, 2025
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative GroupMaxwell Otiato, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, et al.
European Urology Focus|February 7, 2021
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
Pageof 42